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Summary
 
The incidence of septic shock caused by gram-positive bacteria has risen markedly in the last
few years. It is largely unclear how gram-positive bacteria (which do not contain endotoxin)
cause shock and multiple organ failure. We have discovered recently that two cell wall frag-
ments of the pathogenic gram-positive bacterium 
 
Staphylococcus aureus,
 
 lipoteichoic acid (LTA)
and peptidoglycan (PepG), synergize to cause the induction of nitric oxide (NO) formation,
shock, and organ injury in the rat. We report here that a specific fragment of PepG, 
 
N
 
-acetyl-
 
glucosamine-
 
b
 
-[1
 
fi
 
4]-
 
N
 
-acetylmuramyl-
 
l
 
-alanine–
 
d
 
-isoglutamine, is the moiety within the
PepG polymer responsible for the synergism with LTA (or the cytokine interferon 
 
g
 
) to induce
NO formation in the murine macrophage cell line J774.2. However, this moiety is also present
in the PepG of the nonpathogenic bacterium 
 
Bacillus subtilis
 
. We have discovered subsequently
that 
 
S. aureus
 
 LTA synergizes with PepG from either bacterium to cause enhanced NO forma-
tion, shock, and organ injury in the rat, whereas the LTA from 
 
B. subtilis
 
 does not synergize
with PepG of either bacterium. Thus, we propose that the structure of LTA determines the
ability of a particular bacterium to cause shock and multiple organ failure (pathogenicity), while
PepG acts to amplify any response induced by LTA.
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A
 
resurgence of nosocomial gram-positive infections was
first noticed in the early 1980s. Today, between one
third and half of all cases of sepsis are caused by gram-posi-
tive organisms, and it is likely that the incidence of gram-
positive sepsis will continue to rise and predominate in the
years to come (1, 2). Gram-positive organisms do not con-
tain LPS (or endotoxin), which is the cell wall component
of gram-negative bacteria responsible for the initiation of
gram-negative septic shock. However, gram-positive bac-
teria can cause septic shock and multiple organ failure
without causing endotoxemia (3, 4), and endotoxin is not
always found in the serum of patients with septic shock (1,
2). The cell wall of gram-positive bacteria contains lipotei-
choic acid (LTA)
 
1
 
 and peptidoglycan (PepG), which them-
selves can activate leukocytes, stimulate the generation of
proinflammatory cytokines, and hence, cause a moderate
systemic inflammatory response syndrome (5–8).
The endogenous vasodilator autacoid nitric oxide (NO)
is generated by three different isoforms of NO synthase
(NOS), two of which are expressed constitutively (eNOS
in endothelium, nNOS in brain), the third (iNOS) induced
by endotoxin (LPS) or cytokines (9). There is now substan-
tial evidence that an enhanced formation of NO by iNOS
contributes to the circulatory failure (hypotension, and vas-
cular hyporeactivity to vasoconstrictors) and possibly the
organ injury associated with endotoxemia (10–12).
LTA is a macroamphiphile, equivalent to LPS in gram-
negative bacteria, containing a substituted poly-glycero-
 
1
 
Abbreviations used in this paper:
 
 AE-ITU, aminoethyl-isothiourea; ALT, ala-
nine aminotransferase; 
 
d
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l
 
-ala, 
 
d
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l
 
-alanine; iNOS, inducible NOS;
 
l
 
-lys, 
 
l
 
-lysine; L-NMMA, 
 
N
 
G
 
-methyl-
 
l
 
-arginine; LTA, lipoteichoic acid;
MTT, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide; NAG,
 
N
 
-acetylglucosamine; NAM, 
 
N
 
-acetylmuramic acid; NAG-NAM-
 
l
 
-ala-
 
d
 
-isoglutamine, 
 
N
 
-acetylglucosamine-
 
b
 
-[1
 
fi
 
4]-
 
N
 
-acetylmuramyl-
 
l
 
-alanine-
 
d
 
-isoglutamine; NO, nitric oxide; NOS, NO synthase; PepG, peptidoglycan;
RASMC, rat aortic smooth muscle cell(s); SALE
 
, Staphylococcus aureus
 
 lytic
enzyme.
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phosphate backbone attached to a glycolipid (for a review,
see reference 13). The glycolipid content in LTA resembles
the bacterial membrane composition, which usually varies
in a genus-specific manner (13, 14). LTA from 
 
Staphylococ-
cus aureus
 
 can cause a moderate induction of iNOS (15–17)
which (in murine macrophages) requires the activation of
tyrosine kinases and NF-
 
k
 
B (17). Although LTA from 
 
S.
aureus
 
 can cause moderate hypotension in the rat, LTA
(unlike 
 
S. aureus
 
 itself) does not cause multiple organ failure
or death in this species (16). However, we have discovered
recently that LTA and PepG act in synergy to release TNF-
 
a
 
and IFN-
 
g
 
, to induce iNOS, and to cause shock and multi-
ple organ failure in anesthetized rats (18, 19). The mecha-
nism by which LTA and PepG act in synergy is not clear.
In addition, it is not known which of the structural compo-
nents of PepG (or LTA) is essential for the observed syner-
gism.
PepG is a large polymer that provides stress resistance
and shape-determining properties to bacterial cell walls.
This polymer contains long sugar chains of two alternating
sugar derivatives, 
 
N
 
-acetylglucosamine (NAG) and 
 
N
 
-acetyl-
muramic acid (NAM), which are highly cross-linked by
peptide subunits and bridges (see Fig. 1). The peptide sub-
unit (or stem peptide) consists of alternating 
 
l
 
– and 
 
d
 
–amino
acids, up to four or five in length, and is connected to the
COOH group of NAM. Among different bacterial species,
the structure of the sugar chains is highly preserved, while
the composition of the peptide subunits varies.
This study was designed to investigate which of the
structural elements of PepG are essential to synergize with
LTA to cause the induction of iNOS in macrophages, and
shock and multiple organ failure in vivo. Two distinct
gram-positive organisms were used: 
 
S. aureus
 
, a bacterium
most commonly implicated in gram-positive sepsis (1), and
 
Bacillus subtilis
 
, a nonpathogenic bacterium. We have iden-
tified a structural moiety present in the PepG polymer of
both 
 
S. aureus
 
 and 
 
B. subtilis
 
 that is essential to synergize
with LTA or IFN-
 
g
 
 to induce iNOS in macrophages. Fur-
thermore, we provide evidence that the origin of LTA but
not PepG determines whether the cell wall components
from a gram-positive organism synergize to induce iNOS
and multiple organ failure.
 
Materials and Methods
 
Bacterial Cell Wall Components.
 
Cell walls from vegetative
cells of 
 
B. subtilis 
 
and 
 
S. aureus
 
 were prepared as described previ-
ously (20). Secondary polymers (teichoic and teichiuronic acids)
were removed from the PepG by treatment of cell walls (10 mg
dry wt/ml) with 48% vol/vol hydrofluoric acid at 4
 
8
 
C for 24 h.
The pure PepG was then washed six times, by centrifugation
(14,000 
 
g
 
, 5 min) and resuspension in distilled water, until the pH
was neutral before storage at 
 
2
 
20
 
8
 
C. In one study, the PepG
polymer of 
 
S. aureus
 
 was digested by various enzymes to further
investigate the structural requirements of PepG for the induction
of iNOS. The PepG polymer (10 
 
m
 
g/ml) and the coinducer
IFN-
 
g
 
 (10 IU/ml) were incubated in DMEM for 1 h at 37
 
8
 
C
with various enzymes (at 10 
 
m
 
g/ml) which hydrolyze the PepG
polymer at specific points (Fig. 1). Previous studies by Timmer-
man et al. (21) have shown that this procedure is sufficient to
completely digest the PepG polymer.
In one experiment, the LTA extract of 
 
S. aureus
 
 (obtained
from Sigma Chemical Co., Poole, Dorset, UK) was further puri-
fied using an octyl–sepharose column (CL-4B, 1.5 
 
3
 
 11 cm).
LTA dissolved in equilibration buffer consisting of 0.1 M sodium
acetate (pH 4.7) and 15% vol/vol propan-1-ol was loaded on the
column. The column was then washed using equilibration buffer.
Subsequently, bound components from the LTA extract were
eluted using a linear gradient of propan-1-ol (15–100% vol/vol in
equilibration buffer), and fractions of 2 ml vol were collected.
The fractions were freeze dried and resuspended in distilled wa-
ter. Phosphate concentration in the samples was determined as
described by Kusunoki et al. (22).
 
Cell Culture Experiments.
 
Murine macrophages (J774.2; The
European Collection of Animal Cell Cultures, Salisbury, UK)
were cultured in 96-well plates with DME (200 
 
m
 
l/well) con-
taining 10% FCS (GIBCO BRL, Paisley, UK) and 
 
l
 
-glutamine
(4 mM). Rat aortic smooth muscle cells (RASMC, A10 cell line;
The European Collection of Animal Cell Cultures) were cultured
in 96-well plates with RPMI 1640 medium (200 
 
m
 
l/well) con-
taining 10% FCS and 
 
l
 
-glutamine (4 mM). The 96-well plates
containing the cells were then incubated at 37
 
8
 
C in a humidified
incubator until the cells reached confluence. Cultured cells were
activated by the isolated bacterial cell wall components or frag-
ments, and after 24 h, the accumulation of nitrite in the superna-
tant was measured as an indication of iNOS activity. Griess re-
agent (1% sulfanilamide and 0.1% naphthylethylenediamide in 5%
phosphoric acid) was added to the culture medium, and the dif-
ference in OD between 550 and 650 nm was measured. The ni-
trite concentrations were calculated using standard solutions of
sodium nitrite prepared in culture medium (23).
Cell viability was assessed by the mitochondrial reduction of
3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) to formazan (23). After removal of supernatant for nitrite
measurements, cells were incubated with MTT (0.4 mg/ml) for
30 min at 37
 
8
 
C. Medium was removed by aspiration, cells were
solubilized in DMSO, and the reduction of MTT was measured
by spectrometry at 550 nm. Unless otherwise stated, there were
no significant changes in the cell viability after various treatments
of either macrophages or RASMC.
 
Immunoblot (Western Blot) Analysis for iNOS.
 
Western blot analy-
sis was used to determine the expression of iNOS protein. After
exposure of J774.2 macrophages to the relevant cell wall compo-
nents, cells were suspended in homogenization buffer comprised
of Tris-HCl (50 mM), EDTA (10 mM), Triton X-100 (1% vol/
vol), and the protease inhibitors pepstatin A (50 
 
m
 
M), leupeptin
Figure 1. Structure of S. au-
reus PepG. The shaded area on
the PepG monomer shows the
minimal component that ac-
counts for the ability of PepG to
synergize with LTA (or IFN-g)
to induce NO formation in
J774.2 macrophages. The points
at which enzymes lyse PepG are
identified by markers ( filled circle,
mutanolysin or M1; open square,
lysostaphin; filled triangle, SALE).
Numbers, Amino acid position on
the stem peptide.
 307
 
Kengatharan et al.
(0.2 mM), and PMSF (1 mM). The homogenate was boiled for 5
min with gel loading buffer (Tris 20 mM, EDTA 2 mM, SDS 2%
wt/vol, glycerol 20% vol/vol, 2-ME 10% vol/vol, and bromphe-
nol blue 2 mg/ml, pH 6.8) in a ratio of 1:1 (vol/vol). Total pro-
tein equivalents for each sample were resolved on SDS/7.5% vol/
vol polyacrylamide gels and transferred to nitrocellulose. The
membranes were incubated for 20 h at 4
 
8
 
C with a rabbit poly-
clonal antibody raised to murine macrophage iNOS (24). Bands
were detected using a peroxidase-conjugated anti–rabbit IgG and
3,3’-diaminobenzidine or enhanced chemiluminescence (Amer-
sham International, Little Chalfont, Buckinghamshire, UK). The
expression of immunoreactive iNOS was quantified by scanning
densitometry (imaging densitometer model GS-700; Bio-Rad
Laboratories, Hemel Hempstead, Hertfordshire, UK).
 
In Vivo Experiments.
 
Male Wistar rats (240–300 g; Glaxo
Wellcome PLC, Greenford, Middlesex, UK) were anesthetized
with thiopentone sodium (120 mg/kg, i.p.). The trachea was can-
nulated to facilitate respiration, and the rectal temperature was
maintained at 37
 
8
 
C using a homeothermic blanket system (Harvard
Apparatus Ltd., Edenbridge, Kent, UK). The right carotid artery
was cannulated and connected to a pressure transducer (SensoNor
840; SensoNor A.S., Horten, Norway) for the measurement of
mean arterial blood pressure and heart rate (MacLab 8; AD Instru-
ments, Hastings, UK). The jugular vein was cannulated for the ad-
ministration of compounds. Cardiovascular parameters were allowed
to stabilize, and at time 0, animals received (
 
a
 
) 
 
S. aureus
 
 LTA (3 mg/
kg), (
 
b
 
) 
 
B. subtilis 
 
LTA (3 mg/kg), (
 
c
 
) 
 
B. subtilis 
 
PepG (1 mg/kg), (
 
d
 
)
 
S. aureus
 
 LTA (3 mg/kg) and 
 
B. subtilis 
 
PepG (1 mg/kg), (
 
e
 
) 
 
B. sub-
tilis
 
 LTA (3 mg/kg) and 
 
B. subtilis 
 
PepG (1 mg/kg), or (
 
f
 
) saline
(0.3 ml 0.9% NaCl). Hemodynamic parameters were measured for
6 h. The pressor response to norepinephrine was assessed 15 min
before and every hour after the administration of the bacterial cell
wall components. At the end of the experiment at 6 h, a blood
sample was obtained for the measurement of markers of organ fail-
ure. Serum concentrations of creatinine, urea (indicators of the de-
velopment of renal dysfunction), and alanine aminotransferase
(ALT, an indicator of the development of liver injury) (25, 26)
were analyzed by a contract laboratory for veterinary clinical chem-
istry (Vetlab Services, West Sussex, UK). Lungs were collected and
stored (
 
2
 
80
 
8
 
C) for the determination of iNOS activity.
 
Lung iNOS Activity Assay.
 
The activity of iNOS in lung ho-
mogenates was determined by measuring the conversion of
[
 
3
 
H]
 
l
 
-arginine to [
 
3
 
H]l-citrulline in the absence of free calcium.
Frozen lungs were homogenized on ice in a buffer composed of
Tris-HCl (50 mM), EDTA (0.1 mM), EGTA (0.1 mM), 2-ME
(12 mM), and PMSF (1 mM), pH 7.4. Lung homogenates (z100
mg protein) were incubated in the presence of [3H]l-arginine (7.5
kBq per tube of 100 ml), l-arginine (10 mM), NADPH (1 mM),
calmodulin (300 IU/ml), tetrahydrobiopterin (5 mM), l-valine
(50 mM), and EDTA (1 mM) for 30 min at 258C in Tris-buffer.
Reactions were stopped by addition of 1 ml ice-cold Hepes
buffer (pH 5.5) containing EGTA (2 mM) and EDTA (2 mM).
After separation using Dowex 50W (sodium form) columns, the
eluted [3H]l-citrulline activity was measured by scintillation
counting. Experiments performed in the absence of NADPH de-
termined the extent of [3H]l-citrulline formation independent of
iNOS activity.
Materials and Drug Solutions. Unless otherwise stated, all com-
pounds were obtained from Sigma Chemical Co. l-[2,3,4,5-3H]argi-
nine hydrochloride was obtained from Amersham International,
and tetrahydrobiopterin (6R-l-erythro-5,6,7,8-tetra-hydrobiop-
terin) was obtained from Schircks Laboratoire (Jona, Switzerland).
Thiopentone sodium was obtained from Rhône Merieux Ltd. (Har-
low, Essex, UK). The PepG fragments were prepared by Dr. S.J.
Foster (University of Sheffield). S. aureus lytic enzyme (SALE)
was obtained from Dr. L. De Graaf (University of Utrecht,
Utrecht, The Netherlands). Murine iNOS antibody was a gift
from Dr. Claire Bryant (William Harvey Research Institute). All
stock solutions were prepared in nonpyrogenic saline (0.9%
NaCl; Baxter Healthcare Ltd., Thetford, Norfolk, UK), and care
was taken to prevent endotoxin contamination. For cell culture
experiments, all solutions of agents were sterilized by filtration
through a filter (pore size 0.22 mm).
Statistical Analysis. All data are presented as means 6 SE of n
observations. For the cell culture experiments, at least three inde-
pendent experiments were performed in triplicate. In anesthe-
tized rats, the pressor response to norepinephrine was calculated
as the area under the response and expressed as mmHg?min. Sta-
tistical analysis was performed either by one-way analysis of vari-
ance for multiple comparison or by Student’s t test as appropriate.
If the analysis of variance yielded significance (P ,0.05), Dun-
nett’s test for multiple comparisons with one control mean or
Bonferroni’s test for multiple comparison on selected single
means was performed (27).
Results
Structural Requirement of PepG to Synergize with IFN-g or
LTA to Induce iNOS. Incubation of J774.2 macrophages
with PepG from S. aureus (1–30 mg/ml) in the presence of
IFN-g (10 IU/ml) resulted in the accumulation of nitrite
after 24 h (Fig. 2 A). PepG alone (up to 100 mg/ml) did
not cause an increase in nitrite accumulation (Fig. 2 A; 2.0
6 0.1 M nitrite for 100 mg/ml PepG). The enhanced for-
mation of nitrite caused by PepG (10 mg/ml) in the presence
of IFN-g (10 IU/ml) was prevented, in a concentration-
dependent manner, by the NOS inhibitors NG-methyl-
l-arginine (L-NMMA; IC50 5 80 mM) or aminoethyl-
isothiourea (AE-ITU; IC50 5 15 mM) (Fig. 2 B). Western
blot analysis revealed an increase in the expression of an
immunoreactive iNOS protein of z130 kD in J774 mac-
rophages challenged with PepG (10 mg/ml) and IFN-g (10
IU/ml) for 24 h (Fig. 2 C). In contrast, neither PepG nor
IFN-g alone caused the expression of iNOS protein. Addi-
tionally, the expression of iNOS protein in cells treated
with LTA (0.1 mg/ml) and PepG (10 mg/ml) was greater
than the level of iNOS expression caused by these compo-
nents alone (Fig. 2 C).
To further elucidate the structural elements of PepG that
are essential to induce iNOS activity in the presence of
IFN-g, PepG from S. aureus was digested for 1 h with var-
ious enzymes before addition to macrophages. Preincuba-
tion with the N-acetylmuramidases mutanolysin or M1,
which hydrolyze the PepG backbone between NAM and
NAG (see Fig. 1), significantly attenuated the nitrite accu-
mulation caused by S. aureus PepG in the presence of IFN-g
(Fig. 3). Lysozyme, a muramidase which is unable to lyse
PepG derived from S. aureus, did not affect the increase in
nitrite caused by PepG plus IFN-g (Fig. 3). The endopep-
tidase lysostaphin, which breaks the pentaglycine interpep-
tide cross-bridge, markedly enhanced the formation of ni-
trite (Fig. 3). In contrast, SALE, which has both endopeptidase
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and amidase activity (i.e., hydrolyzes the bond NAM–
L-ala, which connects the sugar chain and stem peptide),
prevented the ability of PepG to synergize with IFN-g to
induce nitrite formation (Fig. 3). These effects were spe-
cific for PepG, as the induction of nitrite accumulation by
S. aureus LTA (1 mg/ml) was not affected by pretreatment
with these enzymes (results not shown).
Hydrolysis of the PepG polymer affected the induction
of iNOS by PepG in the presence of IFN-g, suggesting
that a small moiety within PepG is responsible for the syn-
ergism with IFN-g to cause induction of iNOS. To further
elucidate which fragment of PepG is involved, macrophages
were incubated with muropeptides, PepG-constituent amino
sugars, peptides, and related molecules. A concentration-
dependent increase in nitrite formation by macrophages
was observed 24 h after the addition of either the NAG-
NAM-l-ala-d-isoglutamine fragment (EC50 5 40 nM) or
the NAM-l-ala-d-isoglutamine fragment lacking the NAG
residue (EC50 5 100 nM) in the presence of IFN-g (Fig. 4
A). To investigate the specificity of these effects, two stereo-
isomers of NAM-l-ala-d-isoglutamine were tested: NAM-
l-ala-L-isoglutamine and NAM-D-ala-d-isoglutamine. The
maximal induction of nitrite formation was decreased sig-
nificantly with NAM-l-ala-L-isoglutamine and nearly abro-
gated with NAM-D-ala-d-isoglutamine (Fig. 4 A). Other
fragments lacking the NAG-l-ala-d-isoglutamine moiety,
including NAM, NAG, stem peptide (l-ala-d-isoglutami-
nyl-l-lys-d-ala-d-ala), triglycine, and pentaglycine, did not
cause an increase in nitrite formation up to a concentration
of 100 mg/ml when given either alone or in combination
with IFN-g (results not shown). As with the PepG poly-
mer, NAG-NAM-l-ala-d-isoglutamine or NAM-l-ala-
d-isoglutamine alone did not induce nitrite formation in
macrophages (2 6 0.5 and 3 6 1 mM, respectively, at 100
mg/ml).
We have demonstrated previously that the S. aureus
PepG polymer synergizes with LTA from the cell wall of S.
aureus to induce iNOS in macrophages and in the anesthe-
tized rat (18). In agreement with the present observations,
the PepG fragment NAG-NAM-l-ala-d-isoglutamine or
NAM-l-ala-d-isoglutamine synergized with LTA (0.1 mg/
ml) to induce an enhanced formation of nitrite in mac-
rophages (Fig. 4 B). Again, this synergy was stereoselective,
as the induction of nitrite formation was decreased for the
stereoisomers of NAM-l-ala-d-isoglutamine (Fig. 4 B).
None of the other fragments of PepG tested synergized
with LTA to cause the formation of nitrite (results not
shown).
Figure 2. (A) S. aureus PepG concentration-dependently increases the nitrite accumulation over 24 h in the presence (black bars) but not the absence
(hatched bars) of IFN-g. (B) The increase in nitrite formation caused by PepG (10 mg/ml) plus IFN-g (10 IU/ml) was concentration-dependently pre-
vented by either L-NMMA (hatched bars) or AE-ITU (black bars). (C) Western (immuno-)blot analysis of macrophage extracts using an iNOS-specific an-
tibody revealed a significant expression of iNOS protein induced by PepG (10 mg/ml) plus IFN-g (10 IU/ml) (lane d). In contrast, the expression of
iNOS protein in untreated macrophages (lane a) or in macrophages treated with IFN-g (10 IU/ml; lane b) or PepG (10 mg/ml; lane c) was much less.
There was a significantly higher expression of iNOS protein in cells treated with LTA (0.1 mg/ml) and PepG (10 mg/ml) (lane f) compared with LTA
alone (lane e). Data are expressed as means 6 SE of 12 wells from four independent experiments. *P ,0.05 versus (A) untreated cells and (B) PepG plus
IFN-g control response. The Western blot is representative of four separate experiments.
Figure 3. Effects of various enzymes that lyse PepG on the nitrite for-
mation induced by PepG (10 mg/ml) plus IFN-g (10 IU/ml) in mac-
rophages at 24 h. The muramidases, mutanolysin and M1, attenuated sig-
nificantly the nitrite formation caused by PepG plus IFN-g. In contrast,
lysozyme, a muramidase that does not lyse the PepG from S. aureus, did
not affect this response. The endopeptidase lysostaphin significantly en-
hanced the nitrite formation, whereas SALE, which has both endopepti-
dase and amidase activities, completely prevented the nitrite formation.
Data are expressed as means 6 SE of 9–12 wells from three to four inde-
pendent experiments. *P ,0.05 versus PepG plus IFN-g control re-
sponse.
309 Kengatharan et al.
Polymyxin B (an agent that binds and inactivates endo-
toxin) at a concentration sufficient to abolish the increase in
nitrite caused by LPS in macrophages (17) did not affect
the nitrite production caused by either PepG or its frag-
ment NAG-NAM-l-ala-d-isoglutamine in the presence of
IFN-g in the same cells (results not shown).
iNOS Induction after Separation of Commercially Available S.
aureus LTA Extract. There are several studies reporting that
LTA (Sigma Chemical Co.) can induce iNOS activity in
macrophages or RASMC in culture and in vivo in anesthe-
tized rats (15, 16, 28). This commercially available LTA is
extracted by the hot phenol–water procedure and is still
contaminated with various bacterial components, including
polysaccharides, proteins, and nucleic acids. Two recent re-
ports indicate that components other than purified LTA
contribute to (a) the release of IL-6 in a human astrocy-
toma cell line; (b) the release of IL-1, IL-6, and TNF-a
from human monocytes; and (c) the induction of iNOS in
mononuclear cells (8, 29). Therefore, S. aureus LTA ob-
tained from Sigma Chemical Co. was subjected to separa-
tion by hydrophobic interaction column chromatography,
and relevant fractions were obtained. As LTA contains
phosphates, detectable amounts of phosphate were ob-
served in fractions 8–12 (corresponding to material not
bound by the column matrix) and in fractions 36–44 (Fig.
5). Only the latter fractions induced the accumulation of
nitrite in macrophages when given to these cells either
alone or in combination with the PepG fragment NAG-
NAM-l-ala-d-isoglutamine. Most notably, the increase in
Figure 4. Effects of various fragments of PepG in the presence of (A)
IFN-g or (B) LTA (from S. aureus) on the nitrite accumulation in the su-
pernatant of macrophages. The PepG fragments NAG-NAM-l-ala-d-iso-
glutamine (A, circles; B, 1 mg/ml) and NAM-l-ala-d-isoglutamine (A,
squares; B, 1 mg/ml) concentration-dependently synergized with IFN-g
(10 IU/ml) or LTA (0.1 mg/ml) to cause nitrite accumulation. The
NAM-l-ala-L-isoglutamine fragment (A, triangles; B, 1 mg/ml) was less ef-
fective, whereas the fragment NAM-D-ala-d-isoglutamine (A, diamonds;
B, 100 mg/ml) was inactive in synergizing with IFN-g or LTA. Data are
expressed as means 6 SE of 9–12 wells from three to four independent
experiments. LTA (0.1 mg/ml) produced 15 6 1 mM at 24 h.
Figure 5. Purification of LTA from S. aureus with an octyl–sepharose
column. The LTA extract was fractionated on an octyl–sepharose CL-4B
column equilibrated with 0.1 M sodium acetate buffer (pH 4.7) contain-
ing 15% propan-1-ol. The column was successfully eluted with the buffer
described above and a linear gradient of 15–80% propan-1-ol in the same
buffer. Fractions (2 ml each) were collected and tested for (A) phosphate
content as well as (B) ability to induce nitrite formation in macrophages
with or without NAG-NAM-l-ala-d-isoglutamine (1 mg/ml). Data are
expressed as means 6 SE of four wells from six independent experiments.
*P ,0.05 versus baseline, #P ,0.05 versus fractions alone. The chro-
matogram is representative of two independent separations.
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nitrite afforded by these fractions was not affected by poly-
myxin B (0.5 mg/ml; results not shown), demonstrating
that it was not due to the contamination of these fractions
with LPS.
Lack of Synergy between PepG and IFN-g or LTA in
RASMC. Treatment of RASMC for 48 h with S. aureus
LTA resulted in only a small increase in nitrite accumula-
tion, whereas S. aureus PepG, IFN-g, or NAG-NAM-
l-ala-d-isoglutamine did not induce a significant increase
(Fig. 6). LTA synergized with IFN-g in RASMC to in-
duce a marked accumulation of nitrite. However, a combi-
nation of NAG-NAM-l-ala-d-isoglutamine or PepG with
LTA or IFN-g did not significantly enhance the release of
nitrite from these cells compared with treatment with LTA
or IFN-g alone (Fig. 6).
Comparison of Nitrite Formation Induced by S. aureus and B.
subtilis in Macrophages. Incubation of macrophages with
whole heat-killed S. aureus (108 cells/ml) for 24 h resulted
in a marked elevation of nitrite formation (Fig. 7). How-
ever, the induction of nitrite formation by the nonpatho-
genic bacterium B. subtilis (108 cells/ml) was only z30% of
that elicited by S. aureus (Fig. 7).
We confirm that LTA from S. aureus elicits a concentra-
tion-dependent increase in nitrite formation from mac-
rophages (Table 1). In contrast, LTA from B. subtilis (0.01–30
mg/ml) did not cause a significant increase in nitrite pro-
duction from baseline within 24 h (Table 1).
Although incubation of macrophages with PepG from S.
aureus (up to 30 mg/ml, in the absence of IFN-g) did not
result in an enhanced production of nitrite, PepG from B.
subtilis elicited a small but significant increase in nitrite (at
the highest concentration tested; Table 1). The PepG from
S. aureus synergized only with LTA from S. aureus, not
with LTA from B. subtilis, to induce nitrite formation (Fig.
8 A). Similarly, coincubation of macrophages for 24 h with
PepG from B. subtilis and LTA from S. aureus markedly en-
hanced the nitrite formation compared with that elicited by
either component alone, but no synergy was observed be-
tween PepG and LTA from B. subtilis (Fig. 8 B). Further-
more, NAG–NAM–l–ala–d–isoglutamine present in the
PepG monomer of both S. aureus and B. subtilis synergized
only with S. aureus LTA, not with (at 100-fold concentra-
tion) B. subtilis LTA, for the induction of iNOS protein
and nitrite formation in macrophages (Fig. 9).
Synergy between B. subtilis PepG and S. aureus LTA Causes
Vascular Hyporeactivity and Multiple Organ Failure. Treatment
Figure 6. Neither S. aureus PepG (30 mg/ml) nor NAG-NAM-l-ala-
d-isoglutamine (10 mg/ml) potentiated the increases in nitrite caused by
S. aureus LTA alone (100 mg/ml) in the supernatant of RASMC. How-
ever, IFN-g (10 IU/ml) synergized with LTA but not with either NAG-
NAM-l-ala-d-isoglutamine or PepG to cause enhanced formation of ni-
trite. Data are expressed as means 6 SE of four wells from three to four
independent experiments.
Figure 7. Effects of heat-killed
whole bacteria S. aureus (108
cells/ml) or B. subtilis (108 cells/
ml) on the nitrite formation of
macrophages. Data are expressed
as means 6 SE of six wells from
three independent experiments.
*P ,0.05 versus untreated cells,
#P ,0.05 versus S. aureus.
Table 1. Effect of LTA and PepG from S. aureus or B. subtilis on Nitrite Formation in Macrophages
Component
Nitrite formation at concentration (mg/ml)
0.01 0.1 1 10 30
mM mM mM mM mM
S. aureus LTA 1.8 6 0.2 14.0 6 2.3* 39.9 6 1.2* 51.6 6 1.2* 56.8 6 1.7*
S. aureus PepG 1.4 6 0.2 2.0 6 0.1 2.1 6 0.3 2.9 6 0.4 3.3 6 0.8
B. subtilis LTA 1.9 6 0.1 1.7 6 0.1 2.1 6 0.2 2.4 6 0.2 5.7 6 1.1
B. subtilis PepG 2.0 6 0.1 1.5 6 0.1 2.1 6 0.2 6.6 6 0.2 17.0 6 0.9*
Data are given as mean 6 SE of 12 wells from four independent experiments.
*P ,0.05 compared with untreated cells (Dunnett’s test).
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of rats with S. aureus LTA (3 mg/kg) and B. subtilis PepG
(1 mg/kg) resulted in a significant decrease in blood pres-
sure, from 125 6 3 mmHg at time 0 to 84 6 6 mmHg at 6 h
(P ,0.05 compared with sham-operated rats at the same
time point [117 6 3 mmHg]). Similarly, administration of
other cell wall components also produced a delayed hy-
potension, but these were not significantly different from
sham-operated animals (S. aureus LTA [3 mg/kg], 97 6 6
mmHg; B. subtilis PepG [1 mg/kg], 82 6 12 mmHg; B.
subtilis LTA [3 mg/kg], 94 6 7 mmHg; B. subtilis LTA [3
mg/kg] and B. subtilis PepG [1 mg/kg], 89 6 7 mmHg;
n 5 5–7). Only in rats cotreated with S. aureus LTA and B.
subtilis PepG was the delayed hypotension accompanied by
a severe loss in the pressor response elicited by norepineph-
rine compared with sham-operated rats (Fig. 10 A). No
significant change in the pressor response to norepineph-
rine was observed in rats receiving LTA and PepG from B.
subtilis. There were no significant changes in the heart rate
during the course of the experiment in any of the treatment
groups (results not shown).
Administration of S. aureus LTA (3 mg/kg) and B. subti-
lis PepG (1 mg/kg) resulted, within 6 h, in a significant el-
evation of serum levels of ALT (an indicator of hepatocellu-
lar injury), urea (results not shown) and creatinine (indicators
of renal failure), and enhanced activity of iNOS in lung ho-
mogenates compared with sham-operated rats or rats re-
ceiving either component alone (Fig. 10, B–D). Rats re-
ceiving B. subtilis LTA (3 mg/kg) in combination with B.
subtilis PepG did not show a significant rise in the serum
levels of these biochemical markers of organ failure or in
lung iNOS activity.
Discussion
The cell wall component PepG derived from S. aureus
synergizes with IFN-g to cause the induction of iNOS
protein and activity in J774.2 macrophages, as demon-
strated by protein Western blot analysis and the accumula-
tion of nitrite in the supernatant, which was attenuated by
the NOS inhibitors L-NMMA or AE-ITU. In the pres-
ence of IFN-g or LTA, NAG-NAM-l-ala-d-isoglutamine,
a small moiety within the PepG monomer, also caused an
increase in NO formation by these cells. In contrast, nei-
ther of the sugars NAG or NAM nor the stem peptide (l-
ala-d-isoglutaminyl-l-lys-d-ala-d-ala) or the pentaglycine
bridge caused an increase in NO formation in J774.2 mac-
Figure 8. LTA (0.1 mg/ml)
from S. aureus synergized with
PepG from either (A) S. aureus
or (B) B. subtilis to cause nitrite
formation in macrophages. In
contrast, a 100-fold concentra-
tion of LTA from B. subtilis (10
mg/ml) did not synergize with
PepG from either (A) S. aureus
or (B) B. subtilis to cause nitrite
accumulation. The nitrite forma-
tion induced by LTA plus PepG
from B. subtilis is due to PepG
alone (see Table 1). Data are ex-
pressed as means 6 SE of nine
wells from three independent
experiments. *P ,0.05 versus re-
spective basal levels.
Figure 9. LTA from S. aureus (0.1 mg/ml) but not from B. subtilis (10
mg/ml) synergizes with the PepG fragment NAG-NAM-l-ala-d-iso-
glutamine (1 mg/ml) to cause (A) the expression of iNOS protein and (B)
nitrite formation in macrophages. LTA from S. aureus at 0.1 mg/ml alone
produced significant nitrite levels and the expression of iNOS protein,
whereas NAG-NAM-l-ala-d-isoglutamine (10 mg/ml) alone did not
produce any of these responses. Data are expressed as means 6 SE of nine
wells from three independent experiments. The Western blot is represen-
tative of four separate experiments.
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rophages. Taken together, these results strongly suggest that
the NAG-NAM-l-ala-d-isoglutamine moiety accounts for
the induction of iNOS attributed to the whole PepG poly-
mer. This conclusion is further supported by the following
findings. (a) Hydrolysis of the glycosidic bond between
NAG and NAM (sugar backbone of PepG) with two dif-
ferent muramidases (mutanolysin or M1) also reduced the
NO formation elicited by the whole PepG polymer (in the
presence of IFN-g) by approximately one third. We also
found that the NAM-l-ala-d-isoglutamine moiety was less
potent than NAG-NAM-l-ala-d-isoglutamine to induce
this response. (b) Hydrolysis of the amide bond between
NAM and l-ala in PepG with SALE (30) completely abol-
ished the NO formation caused by the whole PepG poly-
mer (in the presence of IFN-g). Similarly, mutanolysin,
M1, or SALE have also been reported to attenuate the for-
mation of TNF-a elicited by PepG from Staphylococcus epi-
dermidis in human monocytes (21). It could be argued that
the observed effects of SALE are due to its ability to cleave
the pentaglycine bridge between PepG monomers rather
than its amidase activity. However, this is not the case, as
the hydrolysis of this glycine bridge by lysostaphin (31) en-
hanced (rather than decreased) the formation of NO. This
finding is not entirely surprising, as the cleavage of the gly-
cine bridge by lysostaphin is likely to facilitate the interac-
tion of the active moeity, NAG-NAM-l-ala-d-isoglutamine,
with the macrophages. These results support our view that
NAM-l-ala-d-isoglutamine is the smallest possible frag-
ment of PepG that is able to synergize with IFN-g to in-
duce iNOS in macrophages, while an extra NAG residue
results in a more potent induction.
We have reported previously that the PepG polymer
synergizes with another gram-positive cell wall compo-
nent, LTA (18). Indeed, the identified active moieties
(NAG-)NAM-l-ala-d-isoglutamine also synergize with LTA
to cause induction of iNOS in macrophages. This synergy
with IFN-g or LTA is stereoselective, as a decrease in ac-
tivity is observed with the stereoenantiomers NAM-l-ala-
L-isoglutamine and NAM-D-ala-d-isoglutamine. This con-
formational requirement suggests a distinct receptor–ligand
interaction. These results are in agreement with reports
demonstrating that NAM-l-ala-d-isoglutamine, also known
as adjuvant or muramyl peptide, is the smallest biologically
active structure of bacterial PepGs (32, 33). Additionally,
computer modeling studies have shown that a specific con-
formation of NAM-l-ala-d-isoglutamine is required to ex-
ert maximal biological activity (34).
Commercially available LTA is prepared by hot phenol–
water extraction of whole bacteria (35) and may still con-
tain a variety of bacterial components coextracted during
the procedure. Further purification of this “crude” LTA
from S. aureus by hydrophobic interaction column chro-
matography shows that the increase in NO formation is
caused by those fractions containing phosphate (a major
component of the poly(glycerophosphate) backbone of
LTA) and eluted at 35–55% vol/vol propanol, the expected
hydrophobicity of LTA (13, 35). Similar results are found
for the synergy of these fractions with NAG-NAM-l-ala-
d-isoglutamine. Thus, the results strongly suggest that puri-
fied LTA induces the formation of NO by macrophages.
The LTA fractions 40 and 43 contain similar phosphate
concentrations; however, the more lipophilic fraction, 43,
Figure 10. Effect of administration of
various cell wall components from S. aureus
and B. subtilis on the (A) pressor response to
norepinephrine, (B) serum ALT, (C) serum
creatinine, and (D) iNOS activity in lung
homogenates. Data are expressed as means
6 SE (n 5 5–7). *P ,0.05 versus sham, #P
,0.05 versus S. aureus LTA alone.
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elicited a fivefold higher increase in NO formation than
fraction 40. This suggests that the activity of LTA to induce
iNOS increases with lipophilicity of the LTA fractions.
Similar results have been reported for two LTA fractions
isolated from Streptococcus faecalis (36). The more lipophilic
LTA fraction causes the release of TNF-a from macro-
phages and regression of tumors in mice, whereas the more
hydrophilic is inactive. After column chromatography, frac-
tions with significant concentrations of phosphate are also
eluted at 15% vol/vol propanol, representing hydrophilic
fractions that do not contain LTA. Kusunoki et al. (22)
have shown that compound(s) in these fractions (and not in
lipophilic fractions containing purified LTA) elicit the re-
lease of IL-6 in human astrocytoma cells. However, in the
present study, the equivalent fractions do not induce the
formation of NO in murine macrophages. Therefore, it is
unlikely that components other than the purified LTA
contribute to the induction of iNOS in macrophages elic-
ited by commercially available LTA extract.
S. aureus is a major cause of nosocomial infections and
gram-positive septic shock (1), whereas B. subtilis is a non-
pathogenic gram-positive bacterium (37, 38). We report
here that macrophages challenged with whole heat-killed
B. subtilis bacteria produce far less NO than macrophages
activated with heat-killed S. aureus. Similarly, LTA from S.
aureus is more potent than LTA from B. subtilis in enhanc-
ing the formation of NO in macrophages. It has been re-
ported that LTA from S. aureus is also more potent in the
activation of arachidonic acid metabolism in mouse mac-
rophages than LTA from B. subtilis (39). The structure of
LTA from S. aureus and B. subtilis is very similar, except
that the glycosylation and alanine substitution of the poly-
glycerophosphate backbone is higher in S. aureus (13, 40,
41). This suggests that the lipophilic portion of LTA may
be important for the biological activity. This notion is sup-
ported by findings that the immunodeterminants of LTA of
various gram-positive bacteria are located mainly in their
polyglycerophosphate moieties, including its glycosyl and
alanyl substituents (42). Also, in the study by Takada et al.
(36), the more lipophilic LTA fraction of S. faecalis with a
high alanine content was more active than the hydrophilic
LTA fraction with a low alanine content. In the present
study, the more lipophilic fraction from LTA of S. aureus
was also associated with higher activity. Thus, the degree of
alanine substitution in LTA may be important for the in-
duction of iNOS in macrophages, and may explain the
lower activity of LTA from B. subtilis, but the exact role of
alanine substitution remains to be further elucidated.
LTA from S. aureus synergizes with NAG-NAM-l-ala-
d-isoglutamine, the active moiety of PepG present in the
PepG of both S. aureus and B. subtilis (33, 43), to induce
iNOS activity in macrophages. In contrast, LTA from B.
subtilis does not synergize with this moiety to enhance the
formation of NO. In support of this, PepG from either S.
aureus or B. subtilis synergizes with LTA from S. aureus but
not from B. subtilis to cause NO formation in these cells.
These results further indicate that the structure of LTA de-
termines whether or not a particular LTA is able to syner-
gize with PepG to induce iNOS activity. The activity of
PepG seems largely dependent on the NAG-NAM-l-ala-
d-isoglutamine moiety, which is one of the most conserved
parts of PepG from (pathogenic and nonpathogenic) gram-
positive organisms (43). The diversity of PepG among
gram-positive organisms is limited to the free combination
of 11 different types of peptide side chains with two types
of cross-linkage (44). Thus, our results suggest that the abil-
ity of gram-positive organisms to induce iNOS activity in
macrophages, and possibly its pathogenicity, reside within
the LTA component, while PepG serves to amplify a given
biological response.
Surprisingly, in this study we found that neither NAG-
NAM-l-ala-d-isoglutamine nor PepG from S. aureus syn-
ergizes with IFN-g or LTA to induce NO formation in
RASMC. The reason for this is not clear, but may be that
these cells do not possess the “receptor” to which PepG
binds to activate these cells (45, 46). On the other hand, it
is possible that the PepG polymer has to be digested by
macrophages to release biologically active fragments, such
as NAG-NAM-l-ala-d-isoglutamine, whereas smooth mus-
cle cells are unable to digest PepG (47). Indeed, B. subtilis
PepG given to alveolar macrophages releases predominantly
NAG-NAM-l-ala-d-isoglutamine (48). But our finding that
direct exposure of smooth muscle cells to this fragment (in
the presence of IFN-g or LTA) does not result in an en-
hanced formation of NO would argue against this possibil-
ity. Thus, the reason underlying this lack of synergy in
smooth muscle cells remains to be established.
Previously, we have shown that the cell wall compo-
nents LTA and PepG from S. aureus synergize in vivo to
cause circulatory and multiple organ failure in anesthetized
rats (18). We find here that LTA or PepG from B. subtilis
when given either alone or in combination to anesthetized
rats does not induce vascular hyporeactivity to norepineph-
rine, hepatic injury, or renal failure. The inability of the
LTA and PepG–teichoic acid complex from B. subtilis to
cause death in mice has been documented previously (37,
38). As in macrophages, PepG from B. subtilis and LTA
from S. aureus synergized to cause vascular hyporeactivity
to norepinephrine, liver injury, renal failure, and an en-
hanced iNOS activity in the lungs of rats (although either
component alone was inactive). Thus, the importance of
the LTA structure for synergy among the cell wall compo-
nents extends from the in vitro (macrophages) to the in
vivo (anesthetized rats) situation. In these experiments, the
circulatory and multiple organ failure is associated with the
induction of iNOS activity, suggesting a causative role for
NO. Previous studies indicate that inhibition of NO syn-
thesis prevents the circulatory failure and liver injury but
not the renal failure elicited by the combined cell wall
components from S. aureus (19). Thus, an enhanced forma-
tion of NO by iNOS accounts for the circulatory failure
and contributes to the organ injury associated with gram-
positive shock.
In summary, NAG-NAM-l-ala-d-isoglutamine is the
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bioactive moiety in PepG responsible for the synergy of
PepG with IFN-g or LTA to induce iNOS in macro-
phages. The finding that LTA from S. aureus but not B.
subtilis synergizes with PepG from either bacterium to in-
duce (a) NO formation in macrophages and (b) iNOS ac-
tivity, shock, and multiple organ failure in anesthetized rats
suggests that the structure of LTA determines the pathoge-
nicity of a particular bacterium, whereas PepG acts to am-
plify any response induced by LTA.
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